• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct30
KELUN PHARMA released FY2025 Q3 earnings on October 30 During-Market (BJT), actual revenue CNY 4.193 B (forecast CNY 5.3 B), actual EPS CNY 0.123 (forecast CNY 0.4542)
01:00
KELUN PHARMA released FY2025 9 Months Earnings on October 30 During-Market (BJT), actual revenue CNY 13.28 B, actual EPS CNY 0.7536
01:00
Oct23
KELUN PHARMA to Release FY2025 Q3 Earnings on October 31 During-Market (BJT), Forecast Revenue CNY 5.3 B, EPS CNY 0.4542
02:30
Sep22
Colenso Pharma Secretary Reveals Ownership of Kelun Biotech and R&D Pipeline Layout
10:32
Aug28
KELUN PHARMA released FY2025 Q2 earnings on August 28 Pre-Market (BJT), actual revenue CNY 4.693 B (forecast CNY 5.32 B), actual EPS CNY 0.2606 (forecast CNY 0.4692)
01:00
KELUN PHARMA released FY2025 Semi-Annual Earnings on August 28 Pre-Market (BJT), actual revenue CNY 9.083 B, actual EPS CNY 0.63
01:00

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 4.193 B, Net Income 200.04 M, EPS 0.123

Oct21
Distribution Plan(CST)

Cash dividend 0.126 CNY

Distribution Plan(CST)

Cash dividend 0.126 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More